Formosa Laboratories, Inc. (TPE: 4746)

Market Cap	10.53B
Revenue (ttm)	4.69B
Net Income (ttm)	255.94M
Shares Out	120.26M
EPS (ttm)	2.13
PE Ratio	41.16
Forward PE	15.78
Dividend	2.00 (2.30%)
Ex-Dividend Date	Aug 13, 2024

Volume	435,088
Open	88.00
Previous Close	87.50
Day's Range	87.10 - 89.40
52-Week Range	78.00 - 121.00
Beta	0.78
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Formosa Laboratories

Formosa Laboratories, Inc., together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. The company offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, antibiot...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 280
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4746

Financial Performance

In 2023, Formosa Laboratories's revenue was 4.36 billion, an increase of 15.80% compared to the previous year's 3.77 billion. Earnings were 126.24 million, a decrease of -69.16%.